News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Maquet acquires LAAx. OrbusNeich says it called the cops on Boston Scientific. More news
You may also be interested in...
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
CMS proposes a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are contained in the agency’s 2014 physician fee schedule proposal.
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
CMS is proposing a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are proposed in the agency’s 2014 physician fee schedule draft.
Molecular Dx Labs’ Concerns Shift To Coverage Issues With Release Of Interim Medicare Payment Amounts
Now that CMS has posted the interim payment amounts for more than 100 new molecular pathology codes, industry is concerned whether the tests will be covered at all.